Zofran is manufactured by GlaxoSmithKline and was granted FDA approval for use as an anti-nausea medication for cancer patients enduring chemotherapy treatments when it first came on the market.
Then, Zofran was marketed and promoted as a morning sickness remedy for pregnant women. This was done in spite of GSK’s knowledge that the drug could have detrimental effects on the mother’s unborn child. The Department of Justice has brought criminal charges against GSK for this behavior and now the corporation must respond for its actions in civil lawsuits filed on behalf of the innocent children allegedly harmed by the drug. Read the FDA’s Safety Announcements regarding Zofran.